Owen M. Wolkowitz
#160,435
Most Influential Person Now
Researcher ORCID ID = 0000-0003-0655-5042
Owen M. Wolkowitz's AcademicInfluence.com Rankings
Owen M. Wolkowitzphilosophy Degrees
Philosophy
#9229
World Rank
#12758
Historical Rank
Logic
#6216
World Rank
#7711
Historical Rank
Owen M. Wolkowitzbiology Degrees
Biology
#12671
World Rank
#16162
Historical Rank
Neuroscience
#2139
World Rank
#2199
Historical Rank
Download Badge
Philosophy Biology
Owen M. Wolkowitz's Degrees
- PhD Psychiatry Stanford University
- Doctorate Medicine Stanford University
Why Is Owen M. Wolkowitz Influential?
(Suggest an Edit or Addition)Owen M. Wolkowitz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS) (2009) (657)
- Selective alteration of personality and social behavior by serotonergic intervention. (1998) (497)
- Cell aging in relation to stress arousal and cardiovascular disease risk factors (2006) (441)
- Cognitive effects of corticosteroids. (1990) (421)
- Double-blind treatment of major depression with dehydroepiandrosterone. (1999) (414)
- Intensive meditation training, immune cell telomerase activity, and psychological mediators (2011) (405)
- Neuropsychiatric effects of anabolic steroids in male normal volunteers. (1993) (392)
- Leukocyte Telomere Length in Major Depression: Correlations with Chronicity, Inflammation and Oxidative Stress - Preliminary Findings (2011) (385)
- Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. (2010) (358)
- Good stress, bad stress and oxidative stress: Insights from anticipatory cortisol reactivity (2013) (339)
- Stress and telomere biology: A lifespan perspective (2013) (329)
- Dehydroepiandrosterone (DHEA) treatment of depression (1997) (320)
- Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. (1986) (318)
- Resting-State Functional Connectivity of Subgenual Anterior Cingulate Cortex in Depressed Adolescents (2013) (292)
- Depression gets old fast: do stress and depression accelerate cell aging? (2010) (284)
- Oxidative stress, inflammation and treatment response in major depression (2017) (279)
- Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) (241)
- Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study (2014) (240)
- Childhood Trauma Associated with Short Leukocyte Telomere Length in Posttraumatic Stress Disorder (2011) (239)
- Is Serum Brain-Derived Neurotrophic Factor a Biomarker for Cognitive Enhancement in Schizophrenia? (2009) (225)
- Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. (1991) (213)
- Dysregulated relationship of inflammation and oxidative stress in major depression (2013) (211)
- Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids (1994) (206)
- Dynamics of telomerase activity in response to acute psychological stress (2010) (201)
- Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. (1987) (196)
- Does cellular aging relate to patterns of allostasis? An e`xamination of basal and stress reactive HPA axis activity and telomere length (2012) (194)
- Early parental loss and development of adult psychopathology. (1988) (181)
- Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. (2009) (179)
- Treatment of depression with antiglucocorticoid drugs. (1999) (179)
- Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress (2014) (169)
- The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons (2016) (166)
- Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature. (2015) (166)
- Telomere length and cortisol reactivity in children of depressed mothers (2014) (159)
- Antiglucocorticoid treatment of depression: double-blind ketoconazole (1999) (157)
- Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. (2014) (156)
- Neuroleptic responsivity of negative and positive symptoms in schizophrenia. (1987) (153)
- Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications (2001) (151)
- Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. (2011) (149)
- Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women (2009) (147)
- Serum BDNF levels before treatment predict SSRI response in depression (2011) (147)
- Glucocorticoid Medication, Memory and Steroid Psychosis in Medical Illness (1997) (145)
- Glucocorticoids. Mood, memory, and mechanisms. (2009) (144)
- Stress appraisals and cellular aging: A key role for anticipatory threat in the relationship between psychological stress and telomere length (2012) (142)
- The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic Inpatients (1996) (139)
- Treatment of schizophrenia 1999 (1999) (136)
- Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD (2002) (136)
- Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder (2013) (127)
- Ketoconazole administration in hypercortisolemic depression. (1993) (126)
- Prednisone effects on neurochemistry and behavior. Preliminary findings. (1990) (124)
- Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response (2012) (124)
- Benzodiazepine sensitivity in normal human subjects. (1986) (122)
- Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder (2018) (111)
- Dysregulated physiological stress systems and accelerated cellular aging (2014) (104)
- Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder (2018) (100)
- Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms (2012) (98)
- Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. (1990) (94)
- Antidepressant and Cognition‐Enhancing Effects of DHEA in Major Depression (1995) (92)
- Increased pro-inflammatory milieu in combat related PTSD – A new cohort replication study (2017) (91)
- High prevalence of visual hallucinations in research subjects with chronic schizophrenia. (1989) (86)
- DHEA treatment of Alzheimer’s disease (2003) (86)
- Spontaneous brain activity in combat related PTSD (2013) (83)
- Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. (1988) (83)
- The “Steroid Dementia Syndrome”: An Unrecognized Complication of Glucocorticoid Treatment (2004) (83)
- Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients (2005) (80)
- Antiglucocorticoid drugs in the treatment of depression (2001) (79)
- Of sound mind and body: depression, disease, and accelerated aging. (2011) (79)
- Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activity. (1986) (75)
- Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. (2013) (75)
- Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women (1999) (71)
- Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline (2011) (71)
- Physical Activity Moderates Effects of Stressor-Induced Rumination on Cortisol Reactivity (2011) (71)
- Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome". (1987) (69)
- Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist (1990) (68)
- Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers (1988) (66)
- Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation (2016) (65)
- Clinical and biochemical effects of verapamil administration to schizophrenic patients. (1987) (64)
- Movement Disorder, Memory, Psychiatric Symptoms and Serum DHEA Levels in Schizophrenic and Schizoaffective Patients (2001) (63)
- Mitochondrial DNA copy number is reduced in male combat veterans with PTSD (2016) (61)
- Verapamil concentrations in cerebrospinal fluid after oral administration. (1985) (60)
- Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length. (2016) (56)
- Multi-omic biomarker identification and validation for diagnosing warzone-related post-traumatic stress disorder (2019) (55)
- Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. (1986) (55)
- Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal study (2018) (54)
- Anxiety disorders and accelerated cellular ageing (2015) (52)
- Neuroscience-informed auditory training in schizophrenia: A final report of the effects on cognition and serum brain-derived neurotrophic factor (2015) (51)
- Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations (1999) (50)
- Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. (1992) (50)
- Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. (1987) (50)
- Cortisol levels predict cognitive impairment induced by electroconvulsive therapy (2001) (50)
- Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia. (1990) (50)
- Accelerating research on biological aging and mental health: Current challenges and future directions (2019) (49)
- Evidence for disrupted gray matter structural connectivity in posttraumatic stress disorder (2015) (46)
- The “Steroid Dementia Syndrome”: A Possible Model of Human Glucocorticoid Neurotoxicity (2007) (45)
- Cellular aging in depression: Permanent imprint or reversible process? (2014) (45)
- Adverse childhood experiences and leukocyte telomere maintenance in depressed and healthy adults. (2014) (45)
- Dexamethasone increases plasma HVA but not MHPG in normal humans (1985) (44)
- Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. (2002) (43)
- The corticotropin-releasing hormone stimulation test in chronic schizophrenia. (1986) (43)
- A Psychopharmacological Perspective of Cognitive Functions (1985) (43)
- Telomerase activation as a possible mechanism of action for psychopharmacological interventions. (2015) (43)
- Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veterans (2017) (42)
- Peripheral telomere length and hippocampal volume in adolescents with major depressive disorder (2015) (42)
- A DNA methylation clock associated with age-related illnesses and mortality is accelerated in men with combat PTSD (2020) (42)
- Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder (2010) (41)
- Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans (2017) (40)
- Pre-deployment risk factors for PTSD in active-duty personnel deployed to Afghanistan: a machine-learning approach for analyzing multivariate predictors (2020) (40)
- Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients. (1985) (40)
- Metabolomic analysis of male combat veterans with post traumatic stress disorder (2019) (39)
- RBC folic acid levels and cognitive performance in elderly patients: A preliminary report (1988) (39)
- Plasma norepinephrine in chronic schizophrenia. (1990) (38)
- Methylphenidate-induced cardiac arrhythmias. (1986) (37)
- Psychoneuroendocrinology: The Scientific Basis of Clinical Practice (2003) (37)
- PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression (2015) (37)
- Plasma serotonin levels are associated with antidepressant response to SSRIs. (2019) (37)
- Neurobiologic Correlates (1986) (36)
- Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation (2004) (36)
- Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls. (1986) (36)
- Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder. (2017) (36)
- Behavioral implications of lowering cholesterol levels: a double-blind pilot study. (2003) (34)
- Antiglucocorticoid treatments in psychiatry (1997) (34)
- “GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder (2020) (34)
- Leukocyte telomere length: Effects of schizophrenia, age, and gender. (2017) (34)
- Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity (2017) (33)
- Repeated psychological stress testing in stimulant-dependent patients (2005) (33)
- Epigenetic Age in Male Combat-Exposed War Veterans: Associations with Posttraumatic Stress Disorder Status (2018) (33)
- Steroid modulation of human memory: Biochemical correlates (1993) (32)
- When blue turns to grey: do stress and depression accelerate cell aging? (2008) (32)
- The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression. (1987) (32)
- Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment (1998) (32)
- Association of dimensional psychological health measures with telomere length in male war veterans. (2016) (32)
- Self-destructive dermatoses. (1985) (31)
- Leukocyte Telomere Length Predicts SSRI Response in Major Depressive Disorder: A Preliminary Report (2016) (31)
- Altering Cortisol Level does not Change the Pleasurable Effects of Methamphetamine in Humans (2003) (31)
- Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls–preliminary findings (2014) (31)
- Neurotransmitters, neurosteroids and neurotrophins: New models of the pathophysiology and treatment of depression (2003) (30)
- Elevated plasma F2-isoprostane levels in schizophrenia (2016) (30)
- The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease (2018) (30)
- The Pathophysiologic Significance of Hyperadrenocorticism: Antiglucocorticoid Strategies (1993) (29)
- Beneficial Effects of Nalmefene Augmentation in Neuroleptic-Stabilized Schizophrenic Patients (1993) (29)
- Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls (2016) (29)
- Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia. (1989) (28)
- Single-dose naloxone acutely reduces eating in obese humans: Behavioral and biochemical effects (1988) (28)
- A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder (2015) (28)
- MRI Deep white matter hyperintensity in a psychiatric population (1991) (28)
- Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness. (1987) (27)
- Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia. (1990) (27)
- Rational polypharmacy in schizophrenia. (1993) (26)
- Selective effects of triazolam on memory (2005) (26)
- Low serum brain-derived neurotrophic factor is associated with suicidal ideation in major depressive disorder (2019) (25)
- Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. (1986) (25)
- A population of atypical CD56−CD16+ natural killer cells is expanded in PTSD and is associated with symptom severity (2016) (24)
- Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: Correlations with CSF HVA (1989) (24)
- Dr. Amsterdam and Associates Reply (1982) (24)
- Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression (2017) (22)
- Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings. (1994) (21)
- Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment (2016) (21)
- Long-lasting behavioral changes following prednisone withdrawal. (1989) (21)
- Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder (2021) (21)
- Pathologic gambling and other risk-taking pursuits. (1985) (20)
- Polygenic risk associated with post-traumatic stress disorder onset and severity (2019) (20)
- Accelerated aging in serious mental disorders. (2019) (19)
- Dehydroepiandrosterone (DHEA) and memory in depressed patients (1994) (19)
- Memory facilitation following the administration of the benzodiazepine triazolam. (1995) (19)
- Dysphoria associated with methylphenidate infusion in borderline personality disorder. (1987) (19)
- Mechanistic inferences on metabolic dysfunction in posttraumatic stress disorder from an integrated model and multiomic analysis: role of glucocorticoid receptor sensitivity (2019) (19)
- Effect of naloxone on food consumption in obesity. (1985) (18)
- Cortisol awakening response and cortisol/DHEA ratio associations with hippocampal volume in MDD (2012) (18)
- Antiglucocorticoid strategies in hypercortisolemic states. (1992) (18)
- BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. (2012) (18)
- Double-Blind Antiglucocorticoid Treatment in Schizophrenia and Schizoaffective Disorder: A Pilot Study (2002) (17)
- Neuropsychiatric Effects of Dehydroepiandrosterone (DHEA) (2000) (17)
- Glucocorticoids (2009) (17)
- Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia (1986) (16)
- Vitamin D and inflammation in major depressive disorder. (2020) (16)
- A psychopharmacological perspective of cognitive functions. I. Theoretical overview and methodological considerations. (1985) (16)
- Measurement and interpretation of changes in memory in response to drug treatments. (1992) (16)
- Accelerated biological aging in serious mental disorders (2018) (16)
- Drug trials and heterogeneity in schizophrenia: The mean is not the end (1990) (15)
- Behavioral Side Effects of Corticosteroid Therapy (1993) (15)
- Novel Pharmacological Targets for Combat PTSD-Metabolism, Inflammation, The Gut Microbiome, and Mitochondrial Dysfunction. (2020) (15)
- High levels of mitochondrial DNA are associated with adolescent brain structural hypoconnectivity and increased anxiety but not depression. (2018) (15)
- Specificity of plasma HVA response to dexamethasone in psychotic depression (1989) (14)
- Hormonal changes with cholesterol reduction: a double‐blind pilot study (2004) (14)
- Serotonergic Intervention Increases Affiliative Behavior in Humans (1997) (12)
- Improvement in indices of cellular protection after psychological treatment for social anxiety disorder (2019) (12)
- Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis (2019) (12)
- Posttraumatic stress disorder, symptoms, and white matter abnormalities among combat-exposed veterans (2018) (11)
- Epigenetic biotypes of post-traumatic stress disorder in war-zone exposed veteran and active duty males (2020) (11)
- Metabolic stress effects in normal volunteers and schizophrenic patients. (1988) (11)
- Association of comorbid depression with inpatient outcomes in critical limb ischemia (2019) (11)
- Prednisone-induced behavioral and biological changes in medically healthy volunteers. (1988) (11)
- Neural and molecular mechanisms in anxiety. (1985) (10)
- Hypothalamic-pituitary-adrenal axis dysfunction (1993) (10)
- Depression severity is associated with increased inflammation in veterans with peripheral artery disease (2018) (10)
- Utilization of machine learning for identifying symptom severity military-related PTSD subtypes and their biological correlates (2021) (10)
- Benzodiazepines in Schizophrenia: Prefrontal Cortex Atrophy Predicts Clinical Response to Alprazolam Augmentation (2002) (9)
- A psychopharmacological perspective of cognitive functions. II. Specific pharmacologic agents. (1985) (9)
- Use of the dexamethasone suppression test with mentally retarded persons: review and recommendations. (1990) (9)
- Specificity of memory impairments with triazolam use (1991) (9)
- HPA axis regulation and epigenetic programming of immune-related genes in chronically stressed and non-stressed mid-life women (2020) (9)
- Diazepam-induced amnesia: a neuropharmacological model ofan ???organicamnesic syndrome??? (1987) (9)
- Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man (1992) (8)
- The Role of Dehydroepiandrosterone (DHEA) in Psychiatry (2000) (8)
- Effect of Combat Exposure and Posttraumatic Stress Disorder on Telomere Length and Amygdala Volume. (2020) (8)
- Quantitative electroencephalographic correlates of steroid administration in man. (1993) (8)
- Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans (1990) (8)
- Telomere length is inversely correlated with urinary stress hormone levels in healthy controls but not in un-medicated depressed individuals-preliminary findings. (2017) (8)
- Pre-treatment allostatic load and metabolic dysregulation predict SSRI response in major depressive disorder: a preliminary report (2020) (7)
- Suicidality and corticosteroid psychosis (1990) (7)
- Naloxone's effect on cognitive functioning in drug-free and diazepam-treated normal humans (2004) (7)
- Anxiety disorders and accelerated cellular aging (2014) (7)
- Novel strategies for treatment-resistant depression. (1996) (7)
- Blood-based mitochondrial respiratory chain function in major depression (2021) (6)
- Alternate-day corticosteroid treatment, mood and plasma HVA in patients with systemic lupus erythematosus. (1988) (6)
- Human Pharmacokinetics and Tolerability of L‐365,260, a Novel Cholecystokinin‐B Antagonist (1996) (6)
- Unresolved Issues in Longitudinal Telomere Length Research: Response to Susser et al. (2016) (6)
- Dexamethasone for depression. (1996) (6)
- TRH test in schizophrenic patients and controls (1989) (6)
- Psychoneuroendocrine aspects of treatment-resistant mood disorders (2001) (5)
- WITHDRAWN: Precuneal and amygdala spontaneous activity and functional connectivity in war-zone-related PTSD. (2014) (5)
- Metabolic stress produces rapid immunosuppression in humans. (1987) (5)
- Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals. (2012) (5)
- Dr. Wolkowitz and Dr. Pickar Reply (1992) (4)
- Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patients. (1987) (4)
- Profiles of the pharmacologic response of positive and negative symptoms in schizophrenia. Comment (1987) (4)
- Corrigendum to “Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women” [Brain Behav. Immun. 23 (2009) 446–449] (2012) (4)
- 169. Inflammatory and oxidative stress are highly correlated in unmedicated major depression (2012) (4)
- An immunogenomic phenotype predicting behavioral treatment response: Toward precision psychiatry for mothers and children with trauma exposure (2021) (3)
- Cell aging and resilience: associations between daily emotion regulation and increased telomerase activity (2012) (3)
- Mechanistic insights on metabolic dysfunction in PTSD: Role of glucocorticoid receptor sensitivity and energy deficit (2018) (3)
- Antiglucocorticoid medication effects on specific depressive symptoms (1994) (3)
- Is Depression Associated With Accelerated Aging? Mechanisms and Implications (2019) (3)
- Correction: A DNA methylation clock associated with age-related illnesses and mortality is accelerated in men with combat PTSD (2020) (3)
- Dr. Wolkowitz and Associates Reply (1986) (3)
- Serum brain-derived neurotrophic factor remains elevated after long term follow-up of combat veterans with chronic post-traumatic stress disorder (2021) (2)
- Dimensions of childhood adversity differentially affect biological aging in major depression (2022) (2)
- Benzodiazepine responsivity in schizophrenia (1991) (2)
- Major depressive disorder and accelerated cellular aging (2013) (2)
- 510. Major Depression, Childhood Trauma, Parenting Styles and Oxidative Stress: A Well-controlled Study in Unmedicated Individuals (2017) (2)
- Dexamethasone effects on dopamine and the “prolactin suppression test” (1988) (2)
- Epigenetic Biotypes of PTSD in War-Zone Exposed Veteran and Active Duty Males (2020) (2)
- ANTIGLUCOCORTICO ID TREATMENTS IN PSYCHIATRY (1997) (2)
- ALPRAZOLAM‐NEUROLEPTIC TREATMENT OF SCHIZOPHRENIA: NEW FINDINGS (1992) (2)
- Alprazolam augmentation of neuroleptics in schizophrenia. (1989) (2)
- Hormones, gender and the aging brain: Dehydroepiandrosterone in aging and mental health (2000) (2)
- Brain Signal Variability and Indices of Cellular Protection Predicts Social Anxiety Disorder Treatment Outcome (2019) (1)
- Mechanistic inferences on metabolic dysfunction in PTSD from an integrated model and multi-omic analysis: Role of glucocorticoid receptor sensitivity. (2019) (1)
- 1005. Pre-Treatment Allostatic Load and Metabolic Dysregulation Predict Antidepressant Response in Major Depressive Disorder (2017) (1)
- Telomere lenghth and major depressive disorder: data from a large psychiatric cohort study (2013) (1)
- Pharmacodynamic approaches to benzodiazepine action in man. (1987) (1)
- Telomere length is inversely correlated with urinary stress hormone levels in healthy controls but not in un-medicated depressed individuals – Preliminary findings (2015) (1)
- Alprazolam-neuroleptic treatment in schizophrenia (1989) (1)
- Cortisol Predicts Antidepressant Treatment Outcome, Memory Improvement, and Brain Response to Negative Emotions: The Importance of Aging (2018) (1)
- Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. (2006) (1)
- Positive and Negative Symptoms of Schizophrenia (1986) (1)
- F174. Higher Baseline Plasma Serotonin, and a Greater Decrease in Serotonin Over Treatment, is Associated With Better SSRI Response in MDD (2018) (1)
- 62. Circulating Cell-Free Mitochondrial DNA – a Novel Marker of Mitochondrial Stress Associated With Suicidality and Major Depressive Disorder (2018) (1)
- 187. Maintenance of positive affect and cognitions during acute stress protects against pro-inflammatory reactivity and future depressive symptom increases (2011) (1)
- Posttraumatic stress disorder, symptoms, and white matter abnormalities among combat-exposed veterans (2017) (0)
- Alprazolam Augmentation of Antipsychotic Pharmacotherapy?-Reply (1989) (0)
- Symposium (1987) (0)
- Major Depression Cortisol Abnormalities in Major Depression Cortisol ’ s relationship to psychiatric illness (2017) (0)
- S13. Can Psychological Treatment Slow Down Cellular Aging in Social Anxiety Disorder? An Intervention Study Evaluating Changes in Telomere Length and Telomerase Activity (2018) (0)
- 233. Indices of Cellular Health are Associated With Antidepressant Treatment Response (2018) (0)
- Circulating hematopoietic progenitor cell number is associated with prefrontal cortical thickness, white matter integrity and PTSD duration in combat-exposed veterans (2015) (0)
- Alteration of personality by serotonergic intervention [23] (multiple letters) (1999) (0)
- Peripheral indices of oxidative stress are correlated with hippocampal volume in major depression and in controls (2012) (0)
- Abstract 349: The Association of Comorbid Depression with Inpatient Outcomes in Patients with Critical Limb Ischemia (2018) (0)
- Alprazolam augmentation of neuroleptics in treatment-resistant schizophrenia (1993) (0)
- Subject Index Vol. 27, 1993 (1993) (0)
- Contributors (2019) (0)
- How stress gets under the skin: Exaggerated threat appraisals as a mediator of the relationship between chronic stress and short leukocyte telomere length (2011) (0)
- Title Evidence for disrupted gray matter structural connectivity in posttraumatic stress disorder (2015) (0)
- DHEA effects on human behavior and psychiatric illness. (2002) (0)
- S.05.04 Steroid hormone treatments (2006) (0)
- Response (1989) (0)
- Dr. Knutson and Colleagues Reply (1999) (0)
- Contents of The American Journal of Psychiatry (1987) (0)
- Serum leptin concentrations and telomere length in MDD and in controls (2012) (0)
- Abstract 2218: Analyses of metabolites over time in deployed active-duty service members (2023) (0)
- Models for research in consultation psychiatry. (1990) (0)
- Developing Sensitive Measurements of Mitochondrial Responses to Acute and Chronic Stress (2018) (0)
- 99MTc-HM-PAO spect in the differential diagnosis of geriatric major depression (1989) (0)
- Publisher’s Editorial (1985) (0)
- Alterations in leukocyte transcription factor activities are associated with major depressive disorder and antidepressant treatment (2012) (0)
- From sadness to senescence: cellular effects of psychiatric syndromes (2012) (0)
- ALTERATION OF PERSONALITY BY SEROTONERGIC INTERVENTION. AUTHORS' REPLY (1999) (0)
- Effects of Alprazolam on cognitive function of schizophrenics (1994) (0)
- The Genetic Basis for the Increased Prevalence of Metabolic Syndrome among Post-Traumatic Stress Disorder Patients (2022) (0)
- Sa1845 - Mood and Personality Outcomes before and after Fecal Microbiota Transplantation (2018) (0)
- 9. Dysregulated diurnal cortisol pattern and increased glucocorticoid resistance among pre-menopausal women with major depressive disorder (2012) (0)
- Neurodevelopmental and Neurobiological Aspects of Major Depressive Disorder (2014) (0)
- Maintenance of positive affect & cognitions during acute stress protects against pro-inflammatory reactivity and future depressive symptoms (2011) (0)
- 105. Telomere length and pessimistic attitudes in older women (2008) (0)
- 709. Increased Circulating Blood Cell Counts in Combat-Related PTSD: Associations with Inflammation and Symptom Severity (2017) (0)
- structural brain imaging differentiates behavioral variant of frontotemporal dementia from late life depression : p372 (2016) (0)
- NALTREXONE CHALLENGE FOR HYPERCORTISOLEMIC PSEUDODEMENTIA. AUTHORS' REPLY (1991) (0)
- The biochemical basis for the antipsychotic effects of neuroleptics (1987) (0)
- Associated with Decreases in C-Reactive Protein in Major Depressive Disorder : A Pilot Study (0)
- Editorial: Biological Psychiatry/Pharmacopsychiatry (1985) (0)
- PBMC telomerase activity correlates with hippocampal volume in major depression (2012) (0)
- EDITORIAL (2008) (0)
- Molecular Signatures of Post-Traumatic Stress Disorder in War-Zone Exposed Veteran and Active Duty Soldiers (2022) (0)
- Mitochondrial Respiratory Chain Function in Major Depression (2020) (0)
- Associations of stress and stress-related psychiatric disorders with GrimAge acceleration: review and suggestions for future work (2023) (0)
- Editorial: Biological Psychology/Pharmacopsychology (1985) (0)
- 284. Cortisol predicts cognitive impairment induced by electroconvulsive therapy (1998) (0)
- 228. Cross-Sectional and Longitudinal Studies of Cellular Aging and Related Biomarkers in Combat PTSD (2019) (0)
- Glucocorticoids and mood: clinical manifestations, risk factors and molecular mechanisms. Proceedings of a meeting. June 20-21, 2008. La Jolla, California, USA. (2009) (0)
- LPPHC Adult Outpatient Program (2020) (0)
- 189. Trauma, Stress Mechanisms, and Risk for Psychosis (2017) (0)
- A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder (2014) (0)
- A Phenotype Of Resiliency? Cross-Sectional Psychobiological Differences Between Caregivers Who Are Vulnerable vs. Resilient To Depression, And Controls (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Owen M. Wolkowitz?
Owen M. Wolkowitz is affiliated with the following schools:
